TopStockPlays.com carries an inclusive analysis of DNDN, ILMN, SQNM and INO
Pompano Beach, FL -- (SBWIRE) -- 01/08/2013 -- Dendreon Corporation (NASDAQ:DNDN) remained a bear for the day as it reported the loss of -4.49% and closed at $5.74 after gaining total volume of 8.63 million shares.
DNDN has the total of 154.32 million outstanding shares and its total market capitalization is $885.78 million.
Company’s year to date performance remained quite optimistic with the gain of 8.51% while in last 6 months it lost almost 17.88%. During Last three months company reported a upward momentum of 27.56%.
Where DNDN is Headed Exactly? Find out in This Trend Analysis Reports
Illumina, Inc. (NASDAQ:ILMN) ended its day with the loosing stream with the loss of 7.06% and closed at the price of $50.90 after opening at $49.89. Stock traded during its last trading session with the total traded volume of 7.79 million shares as compared to its average volume of 1.60 million shares.
During the previous session company’s minimum price was $49.16 while it touched its highest price for the day at $51.76. ILMN’s beta value stands at 0.59 points. During last one month company lost -1.32% while its last 5 days shows a decline of 7.03%.
What ILMN’s Charts Are Signaling for Traders? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) opened at the price of $4.99 whereas its previous closing price was recorded at $5.08. SQNM declined 2.87% and traded within the day range of $4.82 - $5.36 for the day, 52 week range of the stock remained in between $2.5 - $5.83.
Total volume of the stock was 7.15 million shares during last trade while its average volume is 3.09 million shares. Company’s total market capitalization stands at $583.11 million along with 114.79 million outstanding shares.
Should SQNM a Buy or Sell Now? Find Out Here
Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) reported the increase of +17.00% to close at $0.620 with the overall traded volume of 4.03 million shares. Its market capitalization was $6.41 million. Its beta value stands at 2.71 times and earning per share was $-0.18.
Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) has the total of 139.36 billion outstanding shares. During last trade company’s minimum price was $0.54 while it touched highest price of $0.63.
Company’s year to date performance remained quiet optimistic with the rise of 24.12%. If we look at last 6 months of trade that is in bullish zone with the gain of 26.56%.
Can INO Show a Strong Recovery? Find out in This Research Report
The TopStockPlays.com expert team is highly experienced in picking the low-priced shares with the biggest profit potential. We uncover the hidden gems in the stock market-shares that can break out for gains of 300%, 400%, even 500% within a few weeks.
PLEASE NOTE WELL: The TopStockPlays.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. Please do your research or consults your financial adviser before making any Investment decision. TopStockPlays.com or its employees will not be responsible for any loss or losses.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)